Islet Autoantibodies | List of Frontiers open access articles

Original Research

Published on 08 Feb 2024

Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay

in Diabetes: Molecular Mechanisms

Devangkumar Tandel
Brigette Hinton
Felipe de Jesus Cortez
David Seftel
Peter Robinson
Cheng-ting Tsai

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1340436

3,762 views
4 citations

Review

Published on 27 Jan 2023

The phenotype of type 1 diabetes in sub-Saharan Africa

in Public Health and Nutrition

Jean Claude Katte
Timothy J. McDonald
Eugene Sobngwi
Angus G. Jones

Frontiers in Public Health

doi 10.3389/fpubh.2023.1014626

11,056 views
31 citations

Review

Published on 24 Dec 2024

The role of B cells in the pathogenesis of type 1 diabetes

in B Cell Biology

Ya-nan Wang
Ruihua Li
Yaxuan Huang
Hui Chen
Hao Nie
Lian Liu
Xiaoting Zou
Jixin Zhong
Bing Zheng
Quan Gong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1450366

9,488 views
16 citations

Original Research

Published on 12 Sep 2022

Early glucose metabolism in children at risk for type 1 diabetes based on islet autoantibodies compared to low-risk control groups

in Clinical Diabetes

Olli Helminen
Tytti Pokka
Susanna Aspholm
Jorma Ilonen
Olli Simell
Mikael Knip
Riitta Veijola

Frontiers in Endocrinology

doi 10.3389/fendo.2022.972714

3,214 views
2 citations

Systematic Review

Published on 03 Feb 2022

The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review

in Clinical Diabetes

Carlo Ross
Zachary J. Ward
Apoorva Gomber
Maira Owais
Jennifer M. Yeh
Ché-L. Reddy
Rifat Atun

Frontiers in Endocrinology

doi 10.3389/fendo.2022.815703

14,130 views
38 citations

Original Research

Published on 25 May 2018

Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital

in Clinical Diabetes

Rumei Li
Jinya Huang
Yifei Yu
Yehong Yang

Frontiers in Endocrinology

doi 10.3389/fendo.2018.00260

7,608 views
8 citations

Mini Review

Published on 04 Nov 2024

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

in Cancer Immunity and Immunotherapy

Lin Zhou
Shuhui Yang
Youtao Li
Cheng Xue
Renping Wan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1448728

7,121 views
10 citations

Mini Review

Published on 23 Jan 2023

Effective assay technologies fit for large-scale population screening of type 1 diabetes

in Diabetes Clinical Epidemiology

Xiaofan Jia
Liping Yu

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.1034698

4,319 views
6 citations

Original Research

Published on 27 Oct 2022

Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Camillo Bechi Genzano
Eugenia Bezzecchi
Debora Carnovale
Alessandra Mandelli
Elisa Morotti
Valeria Castorani
Valeria Favalli
Angela Stabilini
Vittoria Insalaco
Francesca Ragogna

Frontiers in Immunology

doi 10.3389/fimmu.2022.1026416

4,208 views
10 citations

Mini Review

Published on 15 May 2023

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness

in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders

Maxwell J. Fyvie
Kathleen M. Gillespie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1158278

10,619 views
21 citations

Mini Review

Published on 13 Jan 2026

Immune checkpoint inhibitor-associated diabetes mellitus: mechanisms, clinical manifestations, and management strategies

in Clinical Diabetes

Yu Chen
Xiaolu Wang
Shuyun Duan

Frontiers in Endocrinology

doi 10.3389/fendo.2025.1679751

1,287 views

Original Research

Published on 14 Nov 2022

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin

in Cancer Immunity and Immunotherapy

Junlin Qiu
Shuoming Luo
Wenfeng Yin
Keyu Guo
Yufei Xiang
Xia Li
Zhenqi Liu
Zhiguang Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2022.968798

4,508 views
18 citations

Case Report

Published on 23 Jul 2025

Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review

in Pharmacology of Anti-Cancer Drugs

Panpan Ji
Yahui Zhang
Wen Zhang
Bing Leng
Ruifang Nie
Chengwu Shen
Hengcai Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1499796

1,674 views
1 citation

Original Research

Published on 04 Jan 2022

Prevalence of Inflammatory Pathways Over Immuno-Tolerance in Peripheral Blood Mononuclear Cells of Recent-Onset Type 1 Diabetes

in Autoimmune and Autoinflammatory Disorders

Aritania Sousa Santos
Edécio Cunha-Neto
Nelson Vinicius Gonfinetti
Fernanda Bernardi Bertonha
Pauline Brochet
Aurelie Bergon
Carlos Alberto Moreira-Filho
Christophe Chevillard
Maria Elizabeth Rossi da Silva

Frontiers in Immunology

doi 10.3389/fimmu.2021.765264

9,150 views
28 citations

Original Research

Published on 13 Nov 2023

Impact of GAD65 and IA2 autoantibodies on islet allograft survival

in Diabetes Therapies

Joana R. N. Lemos
Raffaella Poggioli
Jonathan Ambut
Nujen C. Bozkurt
Ana M. Alvarez
Nathalia Padilla
Francesco Vendrame
Camillo Ricordi
David A. Baidal
Rodolfo Alejandro

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2023.1269758

3,085 views
4 citations

Original Research

Published on 28 Jul 2022

Apparent Insulin Deficiency in an Adult African Population With New-Onset Type 2 Diabetes

in Diabetes Clinical Epidemiology

Davis Kibirige
Isaac Sekitoleko
Priscilla Balungi
William Lumu
Moffat J. Nyirenda

Frontiers in Clinical Diabetes and Healthcare

doi 10.3389/fcdhc.2022.944483

3,453 views
8 citations

Articles

Advances in risk predictive performance of pre-symptomatic type 1 diabetes via the multiplex Antibody-Detection-by-Agglutination-PCR assay

The phenotype of type 1 diabetes in sub-Saharan Africa

The role of B cells in the pathogenesis of type 1 diabetes

Early glucose metabolism in children at risk for type 1 diabetes based on islet autoantibodies compared to low-risk control groups

The Prevalence of Islet Autoantibodies in Children and Adolescents With Type 1 Diabetes Mellitus: A Global Scoping Review

Islet Autoantibody Patterns in Patients With Type 2 Diabetes Aged 60 and Higher: A Cross-Sectional Study in a Chinese Hospital

A comprehensive review of immune checkpoint inhibitor-related diabetes mellitus: incidence, clinical features, management, and prognosis

Effective assay technologies fit for large-scale population screening of type 1 diabetes

Combined unsupervised and semi-automated supervised analysis of flow cytometry data reveals cellular fingerprint associated with newly diagnosed pediatric type 1 diabetes

The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness

Immune checkpoint inhibitor-associated diabetes mellitus: mechanisms, clinical manifestations, and management strategies

Characterization of immune checkpoint inhibitor-associated fulminant type 1 diabetes associated with autoantibody status and ethnic origin

Case Report: Tislelizumab-induced insulin-dependent diabetes mellitus: a case report and literature review

Prevalence of Inflammatory Pathways Over Immuno-Tolerance in Peripheral Blood Mononuclear Cells of Recent-Onset Type 1 Diabetes

Impact of GAD65 and IA2 autoantibodies on islet allograft survival

Apparent Insulin Deficiency in an Adult African Population With New-Onset Type 2 Diabetes